MT
MapLight Therapeutics, Inc.
SEC filingBiotechnology · Redwood City, CA
Amount raised$188.2Msold at filing
Total offering$372.4M$184.3M still open
Investors in the raise19count reported to the SEC
FiledJul 28, 2025first sale Jul 18, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Kristopher A HansonExecutive Officer
Timothy A GarnettDirector
George A PavlovDirector
Peter A BisgaardDirector
Erin A FoffExecutive Officer
Anatol A KreitzerExecutive Officer
Jim A TrenkleDirector
James A LillieExecutive Officer
Maria A WalkerDirector
Christopher A KroegerExecutive Officer, Director
Jonathan A GillisExecutive Officer
Vishwas A SetiaExecutive Officer
Executive officers, directors and promoters as listed on the Form D.